6 TECH OUTLOOKOctober - 2019Copyright © 2019 ValleyMedia Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.OCTOBER - 05 - 2019, Vol 05 - 14 Published by ValleyMedia Inc. To subscribe to Pharma Tech OutlookVisit www.pharmatechoutlook.com Editor-in-ChiefStacey SmithVisualizerAsher BlakeJohn GothamEditorial StaffAaron Pierce Ava GarciaJenna VegasJoshua ParkerJustin SmithKatherine JonesSalesBrian Thomasbrian@pharmatechoutlook.comPhone: 510.996.5173EditorialStacey Smith Editor-in-Chiefeditor@pharmatechoutlook.comAmid the growing demand for personalized medicine, the pharma and life sciences industries are striving to overcome the traditional challenges ranging from faulty clinical trials, lack of access to accurate patient data, and dearth of competitive differentiation. Besides, standard statistical methodologies--like regression--make data analysis time-consuming, which negatively impacts drug development. However, innovative technologies have come to the rescue. Artificial intelligence (AI), machine learning, and natural language processing (NLP) improve the quality of the production operations by allowing researchers to better connect with the patients and understand them comprehensively. These technologies, combined with various analytics tools, facilitate sales executives in quickly sharing information with physicians, developing tailored messages, and initiating meaningful interactions with patients. The present-day pharma and life sciences industries need to organize the rising volumes of structured and unstructured data from myriad systems, such as EMRs, into compatible formats, analyze them, and visualize the findings in a whole new fashion. Cutting edge analytical tools and techniques enable these industries to innovate while keeping cost and compliance risks in check. The emergence of cloud-based platforms has resulted in a sea change in how the massive data sets are handled and processed, providing a level-playing field for all companies of all sizes. This edition of Pharma Tech Outlook features a list of leading analytics solution vendors along with insightful articles from thought leaders in the pharma and life sciences analytics arena. We hope the rich industry information included in this edition helps you in your business endeavors. Let us know your thoughts.Enabling Smoother and Efficient Drug DiscoveryTECH OUTLOOKTECH OUTLOOK*Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffsales@pharmatechoutlook.comeditor@pharmatechoutlook.commarketing@pharmatechoutlook.comEmail:Contact Us:Phone:510.556.2402, Fax:510-894-8405
< Page 5 | Page 7 >